MEP of the week

Lobby organisation

The Employers' Union of Innovative Pharmaceutical Companies

Business group · Health & pharma · HQ: Poland · Transparency Register entry

As of 8 October 2026, The Employers' Union of Innovative Pharmaceutical Companies appears in 3 declared MEP meetings (2 different MEPs), most often with European People's Party.

3
declared meetings
with current MEPs
2
MEPs met
€50k/yr
declared lobbying spend
self-reported to the register
0.2
lobbyists
full time equivalent

In their own words

“The Employers' Union of Innovative Pharmaceutical Companies INFARMA represents 24 leading pharmaceutical companies engaged in research and development activities and the production of innovative medicines.”

Read the rest of the statementShow less of the statement

“INFARMA’s objective is taking initiatives which positively influence the creation of system solutions in the field of healthcare and promoting innovation resulting from research and original medicinal products in accordance with the principles of medicine based on evidence. Such solutions should allow patients access to modern and the most effective treatments so that Polish norms of treatment meet the global standards. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high-quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 3 declared meetings, by the meeting MEP's political group.

European People's Party267%
European Conservatives & Reformists133%

Meetings by year

Declared meetings per calendar year, 2024–2025. Bar length is relative to its busiest year (2 in 2024).

2024
2
2025
1

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Adam Jarubas
2 meetings · EPP
Waldemar Buda
1 meeting · ECR

The 3 most recent declared meetings

DateMEPSubject
30 Sep 2025Waldemar BudaPakiet farmaceutyczny, analiza zmian rynku badań klinicznych
5 Nov 2024Adam JarubasReforma rynku farmaceutycznego UE
5 Mar 2024Adam JarubasReforma rynku farmaceutycznego UE

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.